1. Home
  2. AURA vs CRESY Comparison

AURA vs CRESY Comparison

Compare AURA & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • CRESY
  • Stock Information
  • Founded
  • AURA 2007
  • CRESY 1936
  • Country
  • AURA United States
  • CRESY Argentina
  • Employees
  • AURA N/A
  • CRESY N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • CRESY Real Estate
  • Sector
  • AURA Health Care
  • CRESY Finance
  • Exchange
  • AURA Nasdaq
  • CRESY Nasdaq
  • Market Cap
  • AURA 438.3M
  • CRESY 815.5M
  • IPO Year
  • AURA 2021
  • CRESY 1997
  • Fundamental
  • Price
  • AURA $8.26
  • CRESY $13.38
  • Analyst Decision
  • AURA Strong Buy
  • CRESY
  • Analyst Count
  • AURA 4
  • CRESY 0
  • Target Price
  • AURA $23.00
  • CRESY N/A
  • AVG Volume (30 Days)
  • AURA 179.3K
  • CRESY 291.8K
  • Earning Date
  • AURA 11-12-2024
  • CRESY 02-07-2025
  • Dividend Yield
  • AURA N/A
  • CRESY 7.49%
  • EPS Growth
  • AURA N/A
  • CRESY N/A
  • EPS
  • AURA N/A
  • CRESY N/A
  • Revenue
  • AURA N/A
  • CRESY $751,941,316.00
  • Revenue This Year
  • AURA N/A
  • CRESY N/A
  • Revenue Next Year
  • AURA N/A
  • CRESY N/A
  • P/E Ratio
  • AURA N/A
  • CRESY N/A
  • Revenue Growth
  • AURA N/A
  • CRESY N/A
  • 52 Week Low
  • AURA $6.63
  • CRESY $6.56
  • 52 Week High
  • AURA $12.38
  • CRESY $14.23
  • Technical
  • Relative Strength Index (RSI)
  • AURA 42.15
  • CRESY 59.90
  • Support Level
  • AURA $8.05
  • CRESY $12.42
  • Resistance Level
  • AURA $8.56
  • CRESY $13.27
  • Average True Range (ATR)
  • AURA 0.37
  • CRESY 0.68
  • MACD
  • AURA 0.03
  • CRESY -0.12
  • Stochastic Oscillator
  • AURA 25.00
  • CRESY 73.35

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

Share on Social Networks: